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Abstract 17 
 The analysis of time series data is common in nutrition and metabolism research for 18 
quantifying the physiological responses to various stimuli. The reduction of many data from a 19 
time series into a summary statistic(s) can help quantify and communicate the overall response 20 
in a more straightforward way and in line with a specific hypothesis. Nevertheless, many 21 
summary statistics have been selected by various researchers, and some approaches are still 22 
complex. The time-intensive nature of such calculations can be a burden for especially large 23 
datasets and may, therefore, introduce computational errors, which are difficult to recognize 24 
and correct. In this short commentary, we introduce a newly-developed tool that automates 25 
many of the processes commonly used by researchers for discrete-time series analysis, with 26 
particular emphasis on how the tool may be implemented within nutrition and exercise science 27 
research. 28 
Keywords 29 
Incremental area under the curve; time series data; temporal response; post-prandial. 30 
  31 
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Introduction 32 
It is common practice within the field of nutrition and metabolism research to analyses 33 
serial measurements made over time to determine the temporal pattern of a given response. 34 
Typical examples include metabolic control following nutritional challenges (i.e. oral glucose 35 
or fat tolerance tests; Berthiaume & Zinker, 2002), monitoring of stable isotope enrichment in 36 
various body pools and associated substrate kinetics (Garlick et al., 1989), and markers of 37 
physiological response to exercise such as heart rate and oxygen consumption (Gore & Withers, 38 
1990).  39 
 40 
Such analyses have become increasingly complex and necessary in recent years both 41 
due to technical advancements in measurement tools and due to our growing understanding of 42 
the interactions between various nutritional stimuli. Regarding the former, it is undoubtedly a 43 
mark of progress that modern technologies have enabled many measurements to be made with 44 
higher sampling frequency and thus with greater sensitivity to rapidly fluctuating responses 45 
over time. However, such high-resolution temporal data also bring certain analytical challenges 46 
(such as the control of type I and II error rates due to the number of multiple comparisons), 47 
which can complicate the elucidation and communication of clear conclusions.  48 
 49 
While early studies in many areas of nutrition science may have examined simple 50 
comparisons of treatments (e.g. 20 g carbohydrate versus water/placebo at a single time-point), 51 
the state of current understanding in many areas is now such that further progress requires more 52 
sophisticated factorial designs with multiple levels within each factor, to examine longer term 53 
effects and/or interactions between ingredients that work in concert (e.g. pre-post response to 54 
carbohydrate versus carbohydrate-protein versus water/placebo, etc.). This further evolution is 55 
necessary to detect more subtle and/or context specific effects but, again, introduces additional 56 
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complicating factors, such as the reduced statistical power associated with quantifying 57 
interactive effects between all the additional independent variables (e.g. a 3-way ANOVA: 3 58 
conditions*pre-post*multiple time-points), along with the complications arising when the data 59 
violate the assumption of sphericity (Huck & Cormier, 1995).  60 
 61 
In all the above cases, condensing the time series data down to a summary statistic can 62 
simplify the analysis by removing the temporal element. In the above example, the 3-way 63 
ANOVA with multiple comparisons at many time-points becomes a 2-way condition*time (pre, 64 
post) analysis. Beyond these advantages in relation to statistical analyses, this approach of 65 
using summary statistics facilitates the clear communication of the main findings both in simple 66 
terms for the general public and with complete reporting of individual responses for the 67 
scientific community. For example, graphical presentation of time series data on a line graph 68 
does not readily allow for individual or paired responses to be plotted, whereas this consistency 69 
of observed responses is easily presented as a histogram showing individual summary statistics 70 
(Figure 1). Measures of central tendency certainly have a place to illustrate group effects on 71 
graphs and figures but individual responses to each experimental condition should still be 72 
presented, particularly when sample sizes are relatively small, to facilitate critical evaluation 73 
of data (Weissgerber et al., 2015). 74 
 75 
Despite the above benefits of summary statistics and the common use of time series 76 
experimental designs within the scientific literature, the general approaches and precise 77 
methods of analysis vary considerably between laboratories and experiments (Wolever, 2004; 78 
Matthan et al., 2016). In addition, calculations requiring multiple stages and various equations 79 
are time consuming and susceptible to human error. This short commentary introduces a 80 
downloadable spreadsheet, the Time Series Response Analyser (TSRA), designed specifically 81 
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to automate and standardize many common processes, thus minimizing both the time spent 82 
analyzing data and the probability of computational errors. The TSRA is freely available under 83 
the ‘Author Guidelines’ section of the IJSNEM website 84 
(https://journals.humankinetics.com/view/journals/ijsnem/ijsnem-overview.xml/). This 85 
commentary will highlight a range of time series analysis procedures that can be computed 86 
with the tool, and briefly discuss their utility in the context of exercise and nutrition research. 87 
 88 
Area under the curve (AUC) 89 
The methodological approach to an AUC calculation is particularly variable (Wolever, 90 
2004) and manual calculation is highly susceptible to human error. The AUC can be calculated 91 
using denominations of the trapezoidal rule, where time series data are integrated to form a 92 
single value characterizing the overall response, representative of an area (e.g. blood glucose 93 
concentrations measured in mmol·l-1 at serial time-points over a standard oral glucose tolerance 94 
test are expressed as the product of concentration and time; mmol·l-1·120 min). Figure 2 95 
illustrates a range of AUC options, each of which is described in this section. 96 
 97 
Total AUC is the most straightforward approach, in which an area is calculated relative 98 
to the line representing an ordinate of zero (Matthews et al., 1990). This practice can provide a 99 
valid estimate of the overall exposure to the parameter of interest (i.e. including the value 100 
measured at baseline – e.g. if contrasting 24 h plasma testosterone concentrations between 101 
males and females). However, by the same reasoning, total AUC can be limited by the variation 102 
commonly observed at baseline, despite the best efforts of researchers and participants to 103 
replicate experimental conditions (Altman, 1985). In cases where baseline differences are 104 
apparent and/or it is the response to a stimulus that is of primary interest, the incremental AUC 105 
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relative to another nominal value (generally baseline) may be a more appropriate alternative 106 
(Wolever & Jenkins, 1986). 107 
 108 
Naturally, certain exposures can cause the dependent variable to drop below the value 109 
to which incremental AUC is being calculated. For example, the postprandial response to a 110 
standard oral glucose tolerance test is typically measured across two hours, as the blood glucose 111 
concentrations of healthy participants tend to return to baseline within this time period (Babraj 112 
et al., 2009). Therefore, the blood glucose concentrations of highly insulin sensitive individuals 113 
could feasibly fall below the value measured at baseline, which for an incremental AUC 114 
calculation provides multiple options for analysis. In this instance some researchers may 115 
choose to terminate the calculation at the time-point at which the measured value falls below 116 
the incremental reference value (Ha et al., 1992), while others will include any subsequent 117 
positive segments if the value returns above baseline. Within this latter approach, researchers 118 
could consider negative areas to equal zero (Hofman et al., 2004), or subtract them from the 119 
calculation (Gannon et al., 1989). It should be noted that, while the subtraction of negative 120 
areas follows the principle of mathematical integration, this process is rarely justified but may 121 
occasionally be applied in error. In theory, unless this subtractive process is rationalized, values 122 
representing AUC should always be positive. Moreover, some of the incremental AUC 123 
variations can be applied to the nadir rather than the baseline value (Vorster et al., 1990), which 124 
may be of interest when variables tend to decrease in response to a stimulus, such as 125 
postprandial concentrations of non-esterified fatty acids (Bickerton et al., 2007), or the ‘hunger 126 
hormone’ ghrelin (le Roux et al., 2005). Alternatively, the AUC could be calculated relative to 127 
a pre-determined absolute value or clinical reference threshold that is indicative of a certain 128 
outcome (Monnier et al., 2003). It is beyond the scope of this commentary to discuss each of 129 
these methodologies in any greater detail as they ultimately depend on the context. Suffice to 130 
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say, whilst some AUC calculations are relatively simple, others can become mathematically 131 
complex, particularly those that consider the intersection of certain thresholds. In these 132 
instances, the probability of conceptual and computational errors with manual calculations are 133 
increased, and the clarity with which the AUC values have been derived is reduced. 134 
The TSRA generates AUC results from raw data consistently and instantaneously with 135 
a minimal risk of human error. The tool computes AUC for all treatments simultaneously and 136 
handles each of the aforementioned methodologies under the input of the user. In addition, the 137 
spreadsheet provides transparency by explicitly quantifying the segmental areas that combine 138 
to produce the chosen AUC (which can be valuable information in itself to retain some 139 
reference to the shape of the response curve despite reducing the individual time points into 140 
areas). 141 
 142 
Alternative summary statistics in discrete-time series analysis 143 
 144 
In addition to the AUC calculations computed by the TSRA, the peak and time-to-peak values 145 
for each trial are also included in the output. Errors and inconsistencies in the identification of 146 
these summary statistics are considerably less likely to occur when compared to AUC, as their 147 
definitions are more precise and their calculations are more straightforward. They can however 148 
be particularly informative within certain contexts, and they are therefore briefly discussed in 149 
this section. Table 1 contains definitions, benefits, limitations and examples for each summary 150 
statistic included in the TSRA output. 151 
 152 
Peak 153 
Of the various alternative summary values that can describe a time series response, the 154 
absolute peak is an easily identifiable, interpretable and physiologically meaningful statistic. It 155 
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is simply the highest value attained in the dependent variable across the time window through 156 
which it was measured. Therefore, rather than representing the totality of a response, as is the 157 
case with AUC, this value indicates the maximum measured value of the relevant outcome. 158 
Critically, this statistic should be determined separately for every distinct trial and individual, 159 
accepting that the peak value may occur at different time-points for different response curves. 160 
Thus, the contrast of maximum measured values cannot be ascertained from visual inspection 161 
of the data when plotted as a time series (i.e. it is possible that no single participant’s maximum 162 
value occurred at the apex of the group mean line). The utility of a peak value during the 163 
response to a physiological challenge has been demonstrated in the diagnoses of various 164 
medical conditions such as growth hormone deficiency (Koppeschaar et al., 2004) and 165 
constitutional delay of puberty (Grinspon et al., 2010), and is practical in the application of 166 
diagnostic research due to the absence of any complex calculations. Despite the simplicity of 167 
this summary statistic representing a clear benefit of this approach, contextual limitations do 168 
exist. For example, measurement error is likely to be relatively high when a single data-point 169 
is used to summarize an overall response, and the accuracy is heavily influenced by the true 170 
location of a peak value relative to the frequency with which samples are collected (De Nicolao 171 
et al., 2000). The accuracy of this value may therefore be questioned when sampling frequency 172 
is insufficient and/or the random within-subjects variability or “noise” in the measurement of 173 
the dependent variable is high. 174 
 175 
Time-to-peak 176 
Alongside the reporting of the peak value, the time at which this peak occurs is typically 177 
reported and interpreted by authors. This “time-to-peak” summary statistic indicates the 178 
gradient of the response to the stimulus, demonstrating onset alongside magnitude. For 179 
example, both the AUC and peak values may be similar between treatments, yet the time-to-180 
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peak may still reveal important changes in the shape of the response curve (Figure 3). This 181 
may be useful when assessing the bioavailability of a nutrient or supplement, as it can indicate 182 
the net rate of appearance relative to an alternative condition (Matthews et al., 1990). For 183 
example, Vinson and Bose (1988) included a comparison of a time-to-peak summary statistic 184 
when investigating ascorbic acid bioavailability, in response to the ingestion of equivalent 185 
doses of synthetic and naturally-occurring vitamin C. Importantly, unless a substance is not 186 
endogenously produced and maintains constant disappearance rates, or in the absence of 187 
isotopic tracer methodologies, this method provides fairly limited insight into substrate kinetics. 188 
However, the utility of the time-to-peak summary statistic as a diagnostic tool has been 189 
demonstrated in the context of insulin sensitivity. Specifically, risk-prediction models for 190 
prediabetes were shown to be reliably and independently enhanced by the addition of time-to-191 
peak blood glucose concentration during an oral glucose tolerance test (Chung et al., 2017). 192 
Moreover, the use of this statistic in this context theoretically signified the early-phase insulin 193 
response, which may have provided additional mechanistic insight beyond alternative 194 
summary statistics (Cree-Green et al., 2018). 195 
 196 
A further application of time-to-peak has been to inform methodologies that seek to 197 
identify certain responses, such as the duration and sampling frequency of an oral fat tolerance 198 
test necessary to provide a holistic metabolic profile (Tentolouris et al., 2017). As with all 199 
considerations outlined in this paper, the precise calculations and reported outcomes should 200 
remain specific to the research question and will therefore depend heavily on the context in 201 
which time series data are being analyzed. Moreover, where the magnitude and/or timing of 202 
the peak is of interest, additional measurements should be taken throughout the time window 203 
within which it is expected to occur. 204 
 205 
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Further considerations 206 
 207 
Variability statistics 208 
 Another avenue for investigation of time series data is variability. For example, 209 
measures of variability in the continuous monitoring of glucose concentrations can be a useful 210 
parameter to describe glycemic control (Wijsman et al., 2013). A greater variability in glucose 211 
concentration could indicate a reduced ability to appropriately respond to nutritional stimuli, 212 
reflecting impaired homeostatic regulation and in the context of glucose metabolism, an 213 
increased risk of type-2 diabetes (Ceriello et al., 2008). Within this example, a variety of 214 
methods are available to characterize glycemic variability including overall standard deviation, 215 
standard deviation across fixed time windows (for variability changes across time), range, 216 
interquartile range, percentage coefficient of variation and time spent above/below certain 217 
thresholds (Akintola et al., 2015). Rodbard (2009) discussed these methods from a statistical 218 
standpoint and provided further context-specific options for alternative perspectives on time 219 
series data. Another context in which the variability in a measured marker is of interest within 220 
a certain time window is chronobiology. Whilst this is a particularly interesting avenue for time 221 
series data analysis in nutrition research, it is beyond the scope of the TSRA primarily because 222 
of the circular nature of chronobiological data measured over several biological rhythm periods. 223 
The intricacies of biological rhythm descriptions and summaries are discussed from a statistical 224 
perspective elsewhere (Landler, Ruxton & Malkemper, 2018). The appropriate application of 225 
variability statistics to time series data ultimately depends on the specific research question 226 
being addressed, and the information that each option can provide. Further key considerations 227 
may be the normality of data distribution, which can influence the appropriateness of certain 228 
measures of central tendency and variability, and the associated sensitivity of these approaches 229 
to more extreme values. The TSRA computes both the standard deviation and the coefficient 230 
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of variation for each individual trial, and provides these simple variability statistics within the 231 
standard output. Alternative variability statistics are not calculated by the tool, as the provision 232 
of a finite number of complex options may influence the analytical approach taken by the user. 233 
 234 
Missing values 235 
Missing values may be the result of missed or inappropriately handled samples, errors 236 
in a measurement technique or mistakes during data entry. These can be particularly common 237 
in time series data, as the probability of an error is increased when a large number of samples 238 
are collected (especially where humans and/or technology are involved!). Missing data pose a 239 
problem for the analysis of time series data as the intended temporal resolution within a given 240 
trial is transiently reduced. Key considerations include the amount, the pattern and the cause of 241 
missing data, each of which may influence the methods by which they are resolved. Regarding 242 
the cause, data could be missing completely at random (MCAR), where missing values are 243 
unrelated to any observed values and are therefore a totally random subset of the data. 244 
Alternatively, if missing values are related to observed data, or dependent on the unobserved 245 
values themselves, they are considered to be missing at random (MAR) or missing not at 246 
random (MNAR), respectively (Little & Rubin, 1987). Where data are MCAR, techniques 247 
typically aim to preserve the observed underlying parameters of the variables for which data 248 
are imputed (e.g. means, variances, covariances etc.). However, the systematic nature of data 249 
MAR and MNAR suggest potential bias may have been introduced in these parameter estimates 250 
due to the existence of the missing values. For example, if the accuracy of a measurement 251 
technique utilized during time series data collection is confounded outside a certain range, 252 
especially high and/or low values are likely to be missing more frequently, eliciting an 253 
unrepresentatively skewed distribution (an example of MNAR). Indeed, Bell, King and 254 
Fairclough (2014) demonstrated a greater level of bias in time series summary measures with 255 
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data MAR or MNAR, compared with MCAR, using a simulated randomized controlled trial. 256 
Researchers are therefore recommended to identify the cause of missing time series data and 257 
handle this issue accordingly. 258 
 259 
Individual time-points for continuous time series data are inherently not mutually 260 
exclusive, so it seems appropriate to estimate missing values using known data for a given trial. 261 
The precise method by which this process has been conducted may however be ambiguous. As 262 
AUC calculations follow the trapezoidal rule, this summary statistic would typically use 263 
simplistic linear interpolation to estimate missing values. Briefly, existing points either side of 264 
missing values are connected with a straight line, and these are imputed as a function of time 265 
using the resulting linear equation (Figure 4A). It should be noted that this approach has 266 
limitations, particularly if missing values occur where the true response is likely to have 267 
reached a peak, as a linear connection would undercut this value (Figure 4B). An alternative 268 
approach may be to fit a polynomial curve of appropriate order to the known data and impute 269 
missing values using the resulting polynomial equation. In the context of time series data, 270 
imputing missing values using alternative trials for the same treatment or the same individual 271 
are not recommended, as these approaches are likely confounded by inter-individual variability 272 
and the effect of treatments, respectively. For a comprehensive review of missing value 273 
handling in the context of randomized controlled trials in nutrition, the reader is directed to Li 274 
and Stuart (2019). 275 
 276 
Outliers 277 
 Another contentious topic in the initial screening of data is the identification and 278 
subsequent handling of outliers. Outlier identification typically uses statistical approaches, 279 
such as Tabachnick and Fidell (2007) defining values ≥ 3.29 standard deviations above or 280 
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below the mean as outliers (the probability of obtaining a true sample this extreme is 0.1%). 281 
However, similar to missing values, continuous time series data are unique in that an outlier 282 
may be identifiable by its magnitude in relation to the rest of the response curve. This viewpoint 283 
may however lead to the exclusion of certain values simply because they don’t follow a 284 
relatively smooth pattern which, as measurement error is likely to exist in all samples, may be 285 
too subjective an approach. de Souza and colleagues (2015) advocate for data analyses to be 286 
conducted with and without suspected outliers, to assess whether the main analysis is robust to 287 
these extreme cases. Comprehensive reporting of this sensitivity analysis may then be the most 288 
transparent approach to the handling of outliers. 289 
 290 
Conclusion 291 
The TSRA has been specifically designed to speed up and standardize the calculation 292 
of summary statistics from time series data. Therefore, this tool can be used to validate 293 
calculations, and can then be cited in publications to provide transparency and to verify that 294 
the reported summary statistics are free from error. In turn, readers can have greater confidence 295 
in the reported conclusions. 296 
 297 
 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
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Table 1. Summary of the various summary statistics available in the output of the TSRA. 
Summary 
Statistic 
Definition/Inference Advantages Limitations Examples in Nutrition and 
Exercise Science 
     
Area 
under the 
curve 
A value representative of 
the magnitude of the total 
response to a stimulus 
across a given time period, 
calculated using the 
trapezoidal rule. 
A single value that takes into account 
the two-dimensionality of time-series 
data (e.g. both the magnitude and the 
duration of the response are 
accounted for) 
Inconsistent definitions throughout the 
literature 
Mathematical complexity increases 
probability of human/computational error 
Blood glucose and insulin 
concentration responses to an oral 
glucose tolerance test 
Appetite hormone responses to 
certain meals 
     
Peak The maximum measured 
value attained in response 
to the stimulus. 
Simple identification of the highest 
measured value 
Clearly indicative of the maximum 
instantaneous exposure to the 
stimulus 
Validity dependent on measurement 
frequency relative to true peak, and error 
associated with the measurement 
technique 
 
Diagnosis of diabetes during an 
oral glucose tolerance test 
Exogenous glucose oxidation rates 
during exercise, when comparing 
carbohydrate-based sports drinks 
     
Time to 
Peak 
The time taken to reach the 
maximum measured value. 
The onset of a given 
exposure. 
Simple identification of the time at 
which the highest measured value was 
sampled 
May provide insight into the early-
phase response to a stimulus 
Validity dependent on measurement 
frequency relative to true peak, and error 
associated with the measurement 
technique 
Mechanistic inference may be confounded 
by contributing rates of appearance and 
disappearance 
Early-phase insulin response to an 
oral glucose tolerance test 
Oxygen uptake kinetics at the 
onset of steady-state exercise 
Enhancing post-exercise glycogen 
resynthesis rates 
     
Minimum The minimum value 
attained in response to a 
stimulus. 
Simple identification of the lowest 
measured value 
Validity dependent on measurement 
frequency relative to true nadir, and error 
associated with the measurement 
technique 
Analysis of variables that are 
known to decrease in response to 
a stimulus, such as plasma non-
esterified fatty acid or glucagon-
like peptide-1 responses to 
carbohydrate ingestion 
     
Variability 
Statistics 
The degree to which a 
measured marker varies 
throughout a given period 
of time. 
Calculations can be relatively 
straightforward (e.g. standard 
deviation, coefficient of variation etc.) 
Provides insight into holistic 
homeostatic control mechanisms 
Wide range of variability statistics available 
Susceptible to confounding by the 
existence of outliers 
Glycemic variability with 
continuous glucose monitoring 
data 
Exercise intensity variability during 
endurance events (e.g. heart rate 
or perceived exertion during a 
cycling road race) 
425 
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 426 
Figure Legends 427 
 428 
Figure 1. 90-minute blood glucose concentration response to milkshake ingestion under two 429 
conditions (breakfast-rest vs. breakfast-exercise). Data are presented as individual measured 430 
responses across time (A), and using the incremental area under the curve (AUC) summary 431 
statistic displayed as mean ± 95% confidence intervals with individual measured responses (B). 432 
Real experimental data for nine participants extracted from Gonzalez et al. (2013). 433 
 434 
Figure 2. Illustrations of the range of area under the curve definitions used throughout the 435 
literature. See text for descriptions and examples for each. 436 
 437 
Figure 3. Hypothetical illustration of an individual measured response to a stimulus across 438 
time. The alternative measured responses on each panel demonstrate when area under the curve, 439 
peak and time-to-peak summary statistics all provide different inferences, requiring cautious 440 
and contextual interpretation 441 
 442 
Figure 4. Simple representation of linear interpolation to impute missing data (A), and a 443 
hypothetical time series response demonstrating a key limitation of linear interpolation (B). 444 
